U.S. STOCKS ON THE MOVE- Cenovus Energy, TeraWulf, Alector

By Reuters News

- Wall Street's main indexes were muted at the open on Monday, as technology stocks eased from record highs, while investors looked for fresh clues on the monetary policy path with Treasury yields and oil prices still elevated. .N

** Cenovus Energy CVE.TO

BUZZ- Cenovus falls after agreeing to buy Athabasca in C$5.7 bln deal

** Establishment Labs ESTA.O

BUZZ- Establishment Labs gains on US FDA approval for more Motiva implant sizes

** Bristol Myers Squibb BMY.N

BUZZ- Leerink downgrades Bristol Myers, flags pipeline risks

** TeraWulf WULF.O

BUZZ- TeraWulf doubles power capacity at Kentucky data center campus; shares rise

** Texas Roadhouse TXRH.O

BUZZ- Texas Roadhouse rises after Evercore ISI upgrades stock rating to 'outperform'

** Lumexa Imaging LMRI.O

BUZZ- Lumexa rises after Truist initiates with Buy

** Alector ALEC.O

BUZZ- Alector soars on Genentech deal for experimental Parkinson's drug

** Align Technology ALGN.O

BUZZ- Align slips as brokerage downgrades rating to 'in line' over slowing demand

** Insmed INSM.O

BUZZ- Insmed shares slip as CFO Sara Bonstein steps down

** RXO RXO.N:

BUZZ- RXO gains after C.H. Robinson unveils $5.8 billion acquisition

** Harley-Davidson HOG.N:

BUZZ- Harley-Davidson rises after Citigroup upgrades to "buy"

** GEO Group GEO.N:

BUZZ- GEO rises on $950 mln sale of ICE facility, expanded stock buyback

** Vistra VST.N:

BUZZ- Vistra rises on reports of $4.2 billion US nuclear loan

** Vaxcyte PCVX.O:

BUZZ - Vaxcyte surges on pneumococcal vaccine late-stage trial success

** Estée Lauder EL.N:
BUZZ - Estée Lauder up after Barclays upgrades to 'overweight'

** PTC PTC.O:
BUZZ - PTC surges after Schneider Electric agrees to $22.6 bln buyout deal

** Petrobras , Itau Unibanco , MercadoLibre , Nu Holdings NU.N
BUZZ- Brazilian ADRs rally as Bolsonaro's strong showing lifts sentiment

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.